maximizing biomarker equity: leveraging partnerships to close biomarker disparities in lung cancer
Published 3 months ago • 3 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
2:43
how can we leverage lung cancer biomarker data to address health disparities?
-
4:09
equity in action: addressing biomarker disparities in lung cancer
-
4:56
lung cancer biomarker disparities | how precision medicine and research can help
-
3:41
closing the gap | ensuring equitable access to lung cancer biomarker testing
-
6:06
how can biomarkers help with lung cancer treatment?
-
4:04
improving biomarker testing access for rural lung cancer patients
-
2:41
tailored approaches to lung cancer: the crucial role of biomarker testing
-
5:50
what challenges surround lung cancer biomarker testing?
-
7:05
patient-provider relationship role in lung cancer biomarker testing
-
4:29
empowering providers to explain lung cancer biomarker testing to patients
-
2:40
an expert explains predictive biomarker testing for lung cancer
-
6:46
improving communication around lung cancer biomarker testing
-
3:32
understanding non-small cell lung cancer: types, biomarkers, and treatment insights
-
8:09
how does data inform lung cancer biomarker testing?
-
3:15
how does biomarker testing impact non-small cell lung cancer care?
-
7:44
how can specific biomarkers impact lung cancer progression?
-
29:04
no one missed: empowering lung cancer patients with biomarker insights
-
2:02
when should lung cancer patients receive biomarker testing?
-
3:23
navigating lung cancer biomarker testing | challenges and solutions for timely access